<DOC>
	<DOCNO>NCT02656212</DOCNO>
	<brief_summary>This double-blind , randomize , placebo-controlled , single dose study ( + ) - epicatechin one 30mg dose/day total 7 day</brief_summary>
	<brief_title>Early Phase Pre-Clinical Initial Clinical Research Epicatechin ( Part 2 )</brief_title>
	<detailed_description>This project double-blinded , placebo-controlled , randomize , Phase I study include ( + ) -epicatechin dose seven day . - Subjects meet American Diabetes Association ( ADA ) criteria pre-diabetes , include impaired fasting glucose ( IFG ) [ refer inclusion/exclusion criterion ] . - The Project include : 7 day evaluation single daily dose synthetic ( + ) -epicatechin pre-diabetic individual compare placebo . - The Project 4 outpatient clinic study visit : screening ( Visit 1 ) , randomization ( Visit 2 ) , end study drug ( Visit 3 ) , follow end study ( Visit 4 ) . - This Project 2 telephone visit Primary hypothesis : As study design evaluate safety tolerability , primary hypothesis test . Primary outcome measure . Vital sign safety lab : BP , HR , creatinine , alkaline phosphatase , liver transaminase These study provide initial data ( + ) -epicatechin influence glycemic control individual prediabetes .</detailed_description>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<criteria>Prediabetic base medical history screen result Male female Must 21 75 year age ( inclusive ) Able give inform consent procedure If female , must either postmenopausal test negative pregnancy screen day procedure . Women estrogen therapy include . If female childbearing potential , must practice willing continue practice appropriate birth control entire duration study Medication use stable 4 week prior screen Body Mass Index ( BMI ) &gt; 27 kg/m2 Definition prediabetes : impaired fasting glucose ( IFG , fast glucose = 100125 mg/dL ) and/OR elevate HbA1c ( 5.76.4 % ) , absence risk factor diabetes Type 2 diabetes Pregnancy Younger 21 old 75 year age Clinically significant abnormality liver kidney function ( &gt; 3x upper limit normal ( ULN ) ) , determine last 6 month certify clinical laboratory Recent myocardial infarct stroke ( within 6 month screen ) Blood pressure ( BP ) &gt; 160 mmHg Systolic &gt; 100 mmHg Diastolic Medications thiazolidinediones , steroid , antidepressant , weight loss drug Other disease , besides type 2 diabetes , influence carbohydrate metabolism</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>epicatechin</keyword>
	<keyword>pre-diabetes</keyword>
</DOC>